Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease
Alzheimer's disease (AD) is a progressive, irreversible, fatal brain disease which disturbs
cognitive functions. It affects 35 million people worldwide and the number of people suffering …
cognitive functions. It affects 35 million people worldwide and the number of people suffering …
Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease
The prevalence of neurodegenerative disorders (NDs) has increased recently, with
Parkinson's disease (PD) and Alzheimer's disease (AD) being the two utmost prevalent …
Parkinson's disease (PD) and Alzheimer's disease (AD) being the two utmost prevalent …
Nanotechnology based theranostic approaches in Alzheimer's disease management: current status and future perspective
Background: Alzheimer's disease (AD), a cognitive dysfunction/dementia state amongst the
elders is characterized by irreversible neurodegeneration due to varied pathophysiology. Up …
elders is characterized by irreversible neurodegeneration due to varied pathophysiology. Up …
[HTML][HTML] Natural product-based nanomedicine: Recent advances and issues for the treatment of Alzheimer's disease
Alzheimer's disease (AD) affects the elderly and is characterized by progressive
neurodegeneration caused by different pathologies. The most significant challenges in …
neurodegeneration caused by different pathologies. The most significant challenges in …
Nanotechnology to improve the Alzheimer's disease therapy with natural compounds
MJ Ramalho, S Andrade, JA Loureiro… - Drug delivery and …, 2020 - Springer
Alzheimer's disease (AD) is a form of dementia with high impact worldwide, accounting with
more than 46 million cases. It is estimated that the number of patients will be four times …
more than 46 million cases. It is estimated that the number of patients will be four times …
[HTML][HTML] Advancements in the Application of Nanomedicine in Alzheimer's Disease: A Therapeutic Perspective
Alzheimer's disease (AD) is a progressive neurodegenerative disease that affects most
people worldwide. AD is a complex central nervous system disorder. Several drugs have …
people worldwide. AD is a complex central nervous system disorder. Several drugs have …
[HTML][HTML] Nanomedicine in the management of Alzheimer's disease: State-of-the-art
SN Mir Najib Ullah, O Afzal, ASA Altamimi, H Ather… - Biomedicines, 2023 - mdpi.com
Alzheimer's disease (AD) is a deadly, progressive, and irreversible brain condition that
impairs cognitive abilities. Globally, it affects 32.6 million individuals, and if no viable …
impairs cognitive abilities. Globally, it affects 32.6 million individuals, and if no viable …
[HTML][HTML] Advances in developing therapeutic strategies for Alzheimer's disease
Alzheimer's disease (AD) is a progressive deterioration of brain function, initially
characterized by cognitive deficits, with loss of recent memory and language ability …
characterized by cognitive deficits, with loss of recent memory and language ability …
Nanomaterials in Alzheimer's disease treatment: a comprehensive review
M Faiyaz, MA Ganayee, S Akhtar… - Frontiers in …, 2021 - research.aalto.fi
Alzheimer's, a progressive neurodegenerative disease affects brain and neurons through
enormous reduction in nerve cell regenerative capacity. Dementia and impairment of …
enormous reduction in nerve cell regenerative capacity. Dementia and impairment of …
The potential benefits of nanotechnology in treating Alzheimer's disease
TS Ling, S Chandrasegaran, LZ Xuan… - BioMed research …, 2021 - Wiley Online Library
Alzheimer's disease is a neurodegenerative disorder that is caused by the accumulation of
beta‐amyloid plaques in the brain. Currently, there is no definitive cure available to treat …
beta‐amyloid plaques in the brain. Currently, there is no definitive cure available to treat …
相关搜索
- alzheimer's disease neurotherapeutic applications
- therapeutic perspective application of nanomedicine
- alzheimer's disease nanomedicine in the management
- alzheimer's disease therapeutic perspective
- nanomedicine in management therapeutic potential
- parkinson's disease therapeutic potential
- alzheimer's disease application of nanomedicine
- alzheimer's disease advancements in the application
- alzheimer's disease therapeutic strategies
- alzheimer's disease therapeutic potential
- therapeutic perspective advancements in the application